Delivery Order SPE2DB20D3304-SPE2DB25FW9H2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,589.51 to AmerisourceBergen Drug Corp for 30 tablets of Quelipti 60 mg, a pharmaceutical product used in mental health treatment. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with an ultimate completion date of September 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $64,765.81 on September 8, 2025, for the supply of Queliptta 60 mg tablets (30-count) with an ultimate completion date of October 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $4,276.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Qualiptia 60 mg on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $73,220 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561425664 Quetiapine ER 150 mg tablets. The single delivery order is for 60 tablets to be shipped to a location in Conshohocken, Pennsylvania, with performance required between July 7-10, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support Medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $71,790 to Amerisourcebergen Drug Corporation for 4561475270 QUETIAPINE ER 300 MG TABLET 60S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the specified location in Conshohocken, Pennsylvania by July 13, 2023 to fulfill DLA's requirements. The parent company, Amerisourcebergen Corporation, will support performance through its Amerisourcebergen...
- The Defense Logistics Agency Troop Support Medical awarded a $226,240 delivery order to Amerisourcebergen Drug Corporation for 100-count bottles of the 200 mg tablet formulation of quetiapine fumarate. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing. No additional details were provided regarding the solicitation or whether this delivery order falls under an existing indefinite-delivery/indefinite-quantity contract vehicle. Amerisourcebergen will be the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Quilpta 60 mg tablets (30-count) with a ceiling value of $4,155.56. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract is non-competitive...
- The Defense Logistics Agency awarded a $1,154.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Qualiptia 60 mg, with an ultimate completion date of July 17, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award reflects routine federal pharmaceutical procurement to support military and veteran healthcare systems through the Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.21, is for the delivery of Quetiapine ER 300 mg tablets to support military and veterans' healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW9H2Delivery Order
The Defense Logistics Agency awarded a $5,996.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Queltiapine 60 mg, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor serving military and veteran healthcare systems. This delivery order exemplifies the breadth of AmerisourceBergen's federal pharmaceutical procurement portfolio, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The award reflects the company's established capability to meet federal procurement requirements through open competition and deliver diverse medical products to support Defense Health Agency operations and other government healthcare systems. The Queltiapine supply fulfills ongoing medication needs within the military healthcare supply chain managed through DLA's comprehensive pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/26/25 |